SciFi Futures
← Concepts
Neurotechnology

Commercial memory implants

Installing a detailed false memory of an experience the customer never had, complete enough to be indistinguishable from a real one.

In shortCommercial memory implants, from We Can Remember It for You Wholesale (Philip K. Dick, 1966), is at technology readiness level 2 of 9 (technology concept formulated) at its weakest link. Held back by Mechanistic theory of neural computation. Science status: consistent with known physics; key effects unproven at scale. Estimated new funding to unlock: $8.3B–46B (a floor; some parts are priced only to early research).

Rekal Inc. sells Douglas Quail an extra-factual memory of a trip to Mars as a secret agent, packaged with souvenirs to shore up the implant.
We Can Remember It for You Wholesale by Philip K. Dick, 1966

Closest todayOptogenetically implanted artificial memories in mice; hippocampal stimulation that improves recall of specific content in epilepsy patients.

Dependency stack

Research TRL 1–3Development TRL 4–6Deployment TRL 7–9
Sort by
  • A narrative memory must be expressed in whatever code the hippocampus and cortex use
    • Unknown sufficient level of biological detail
    plausibleTRL 2
    • Wiring diagrams constrain and test circuit models
      ✕3 blockers›
      • Human proofreading of AI segmentation dominates cost; 2025 methods imply tens of billions of dollars for one mouse brain
      • Imaging throughput and storage; a human brain at EM resolution is of order 100+ exabytes of raw data
      • Sectioning or expanding whole large brains without tissue loss or distortion
      TRL 3
      • Ultrastructure must survive preservation before it can be imaged
        ✕3 blockers›
        • Ischemic damage starts within minutes of circulatory arrest, before perfusion can begin
        • Aldehyde fixation may destroy molecular state (phosphorylation, receptor conformation) that could carry memory
        • No assay proves preserved tissue still contains the information an emulation would need
        TRL 4
      • Automated segmentation and tracing of exabyte-scale image volumes
        ✕2 blockers›
        • Grid power and interconnection queues
        • Advanced-node chip and HBM memory supply
        TRL 8
  • Installing a chosen memory means writing a specified engram
    ✕4 blockers›
    • Human engrams cannot be labeled; the mouse toolkit depends on transgenic c-fos tagging
    • Memory is distributed across an engram complex in many regions, not one addressable site
    • Writing content requires knowing the ensemble code for arbitrary experience, which is unknown
    • Specificity; stimulation that strengthens one memory also perturbs neighbours
    plausibleTRL 3
    • Writing a memory requires knowing what code represents its content
      plausibleTRL 2
    • Activity-dependent labeling in humans would need brain-wide gene delivery
      ✕3 blockers›
      • Receptor targeting is species-specific; capsids binding human TfR1 often fail in macaque
      • Pre-existing anti-AAV immunity excludes a large fraction of patients and blocks redosing
      • Dose needed for brain-wide coverage drives liver toxicity and manufacturing cost
      TRL 4
      • Designed capsid and shuttle proteins are the main route to receptor-specific transcytosis
        ✕1 blocker›
        • Designing catalysis and conformational dynamics
        TRL 6
    • Engram ensembles must be addressed at single-cell scale in deep structures
      ✕2 blockers›
      • Tissue response degrades signal over years
      • Channel count and wireless bandwidth
      TRL 6
      • Channel count is limited by wireless data and power budget
        ✕3 blockers›
        • Tissue heating caps implant power at a few hundred milliwatts, which bounds radio and compute
        • Raw broadband neural data exceeds the link, forcing on-implant spike detection and compression
        • Battery or wireless-power lifetime versus the decades a permanent interface implies
        TRL 5
        • Implant power density sets what telemetry and on-board compute are affordable
          ✕2 blockers›
          • Cycle life of lithium-metal anodes
          • Thermal runaway safety
          TRL 6
  • Activity-dependent labeling of human engrams would need brain-wide gene delivery
    TRL 4
  • Engram ensembles in deep structures must be addressed at single-cell scale
    TRL 6
  • An implanted memory must contain sensory content, not just an association
    ✕3 blockers›
    • Models are subject-specific; decoders do not transfer across brains without recalibration
    • Non-invasive signals are slow and spatially coarse; invasive coverage is a few square centimetres
    • Encoding (write) models are far behind decoding; we cannot specify the activity for an arbitrary percept
    TRL 3

Who could unlock it

Mechanistic theory of neural computationTRL 2bottleneck
  • Philip ShiuResearcher, Eon Systems
    Built the leaky integrate-and-fire whole fly brain model that predicts sensorimotor circuit responses (Nature 2024)
  • Srinivas TuragaResearcher, HHMI Janelia Research Campus
    Co-led connectome-constrained networks that predict neural activity across the fly visual system (Nature 2024)
  • Larry AbbottResearcher, Columbia University
    Theoretical neuroscientist; co-director of the Zuckerman Institute's Center for Theoretical Neuroscience
  • Allen InstituteAcademic lab
    MICrONS functional connectomics and a 230,000-cell biophysical model of mouse visual cortex
Engram-level memory read and writeTRL 3
  • Susumu TonegawaResearcher, MIT Picower Institute
    His lab first optogenetically reactivated and implanted false memories in tagged engram cells in mice (2012-2013)
  • Sheena JosselynResearcher, SickKids and University of Toronto
    Showed engram allocation, erasure and artificial memory formation in mice; 2025 Cell paper on stress-inflated engrams
  • Steve RamirezResearcher, Boston University
    Engram manipulation to alleviate maladaptive memory states in mice
  • Robert HampsonResearcher, Wake Forest University School of Medicine
    Hippocampal memory-decoding-model stimulation facilitated content-specific recall in epilepsy patients (Front. Comput. Neurosci. 2024)
Systemic delivery of agents across the blood-brain barrierTRL 4
  • Benjamin DevermanResearcher, Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard
    Engineered BI-hTFR1, an AAV9 capsid reprogrammed to bind human transferrin receptor, giving 40-50x more CNS expression than AAV9 in human TFRC knock-in mice (Science, 2024)
  • Denali TherapeuticsCompany
    Its TransportVehicle platform produced AVLAYAH (tividenofusp alfa), approved by the FDA in March 2026 as the first biologic specifically designed to cross the blood-brain barrier
  • Voyager TherapeuticsCompany
    Used its TRACER platform to find cross-species BBB-penetrant capsids and identified ALPL as the receptor they use; VCAP-102 gave 20-400x more brain gene transfer than AAV9 in primates (2025)
  • Sangamo TherapeuticsCompany
    Reported its STAC-BBB capsid achieving widespread brain transduction after intravenous dosing in non-human primates at clinically relevant doses (2024)
High-density chronic neural interfacesTRL 6
  • NeuralinkStartup
    Raised $650M Series E in 2025; human trials in the US, Canada, UAE and UK
  • ParadromicsStartup
    FDA IDE in November 2025; first participant achieved real-time speech with the fully implanted Connexus BCI (2026)
  • Precision NeuroscienceStartup
    Surface microelectrode arrays in 50+ patients; 2025 Nature Biomedical Engineering paper on minimally invasive delivery
  • SynchronStartup
    Raised $200M Series D in November 2025 (total $345M) for the endovascular Stentrode and a next-generation high-channel interface

Beyond engineering

  • Consent when the product is indistinguishable from the customer's own past
  • Forensic unreliability of all memory testimony once implants exist